IL23A and psoriasis: Studies of skin samples from patients treated with anti-tumour necrosis factor (anti-TNF)-α agents have confirmed that DCs and T cells play a role in the pathogenesis of psoriasis, and anti-TNF-α has been shown to regulate both Th17 responses and IL-23 and Th17 cytokine expression in lesional psoriatic skin [8, 9].